Your Article Summary
See Latest ArticlesAntiangiogenic strategies for treatment of malignant gliomas
Neurotherapeutics, 07/01/09
Chi AS et al. - A review of antiangiogenic strategies for treatment of malignant gliomas (MG) summarizes clinical experience with antiangiogenic therapy in MG pts, major issues for use and development of these agents, and strategies based on initial gains seen with antiangiogenic agents.
Methods- Review of antiangiogenic strategies for treatment of MG
- Studies are ongoing for numerous antiangiogenic agents with diverse mechanisms of action in treatment of GBM pts
- Early clinical trials suggest that antiangiogenic drugs, which target blood vessels of these highly angiogenic tumors, may have clinical benefit in GBM pts
- Antiangiogenic agents have potent antiedema and steroid-sparing effects; emerging data suggest modest improvement in progression-free survival
- Post-treatment with antiangiogenic agents, a major challenge is interpretation of radiographic changes
- Reliable radiographic and biologic markers are lacking to predict which pts benefit from treatment and accurately indicate response and progression during therapy
- Most pts treated with antiangiogenic drugs eventually progress
Related Articles
MK886-induced apoptosis depends on the 5-LO expression level in human malignant glioma cells
Journal of Neuro-Oncology, 11/04/09
Relevance Score: 68%
Enzastaurin induces H2AX phosphorylation to regulate apoptosis via MAPK signalling in malignant glioma cells
European Journal of Cancer, 11/19/09
Relevance Score: 67%
Methyl-L-11C-Methionine PET as a Diagnostic Marker for Malignant Progression in Patients with Glioma
The Journal of Nuclear Medicine, 11/18/09
Relevance Score: 67%
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma
Neuro-Oncology, 10/06/09
Relevance Score: 67%
Role of a second chemotherapy in recurrent malignant glioma patients who progress on bevacizumab
Neuro-Oncology, 10/06/09
Relevance Score: 67%
Today in Neurologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Prognostic Significance of Growth Kinetics in Newly Diagnosed Glioblastomas Revealed by Combining Serial Imaging with a Novel Biomathematical Model
Cancer Research, 12/08/09
Recognition and Killing of Brain Tumor Stem-Like Initiating Cells by CD8+ Cytolytic T Cells
Cancer Research, 12/08/09
Identification of membrane-type 1 matrix metalloproteinase tyrosine phosphorylation in association with neuroblastoma progression
BMC Cancer, 12/08/09